# The role of palmitoylation in cardiac signal transduction and disease pathogenesis

> **NIH NIH R00** · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 2021 · $248,999

## Abstract

Abstract/Project Summary
 Heart disease continues to be the leading cause of morbidity and mortality in the United States
while treatment options remain limited and largely ineffective. Therefore, a greater understanding of
intracellular signaling in cardiomyocytes that underlies cardiac disease pathogenesis will aid in the
development of novel therapies and drug targets for the treatment of heart disease. Palmitoylation is a
reversible lipid modification that is catalyzed by the recently discovered aspartate-histidine-histidine-
cysteine (zDHHC) family of palmitoyl transferases and has diverse effects on protein function,
including playing critical roles in cellular signaling. Here, we will investigate the role of the palmitoyl
transferase, Godz/Zdhhc3, in the heart. We discovered by yeast two-hybrid screening that Rho GDP
dissociation inhibitor (RhoGDI) directly interacts with Godz and found that overexpression of Godz in
cardiomyocytes enhances RhoGDI palmitoylation, indicating that RhoGDI is a novel Godz substrate.
RhoGDI functions as the master homeostatic regulator of RhoGTPases, signaling molecules with
pivotal roles in cardiac disease pathogenesis. We generated transgenic mice with cardiac-specific
overexpression of Godz to study the role of Godz in vivo. Transgenic Godz mice develop congestive
heart failure that is preceded by enhanced palmitoylation of RhoGDI in the heart and increased
abundance and activity of all cardiac-expressed RhoGTPases, which are regulated by RhoGDI. We
hypothesize that Godz plays instrumental roles in pathogenic signaling in cardiomyocytes by inducing
RhoGTPase levels and activity through palmitoylation of RhoGDI. This proposal will test our
hypothesis with the following aims: 1. To determine the role of Godz-mediated palmitoylation in the
regulation of cardiac signaling and failure and 2. To determine the role of RhoGDI palmitoylation in
RhoGTPase signaling and cardiac disease pathogenesis. The initial portion of this proposal will be
carried out in the laboratory of the renowned molecular cardiology researcher, Dr. Jeffery Molkentin,
where I will investigate how Godz regulates signaling in cardiomyocytes and determine the effects of
cardiac-specific deletion of Godz on cardiac signal transduction, function, and propensity to disease
(Aim 1). In my independent laboratory, I will extend these studies by utilizing mice with a knock-in
mutation for the palmitoylation site of RhoGDI (RhoGDIC79S) to decipher the physiological role of
RhoGDI palmitoylation in the regulation of cardiac RhoGTPase signaling (Aim 2). I will further
investigate Godz-mediated palmitoylation and palmitoylation-dependent signaling in cardiac
homeostasis and pathophysiology in my independent laboratory. This work will uncover mechanisms
whereby dynamic palmitoylation regulates molecular signaling in the heart, which will place me at the
forefront of this emerging field and drive my research program for years to come.

## Key facts

- **NIH application ID:** 10213116
- **Project number:** 5R00HL136695-05
- **Recipient organization:** UNIVERSITY OF MICHIGAN AT ANN ARBOR
- **Principal Investigator:** Matthew Jacob Brody
- **Activity code:** R00 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $248,999
- **Award type:** 5
- **Project period:** 2017-04-01 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10213116

## Citation

> US National Institutes of Health, RePORTER application 10213116, The role of palmitoylation in cardiac signal transduction and disease pathogenesis (5R00HL136695-05). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10213116. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*